|
Amygdala MRI-TIS for Depression
RECRUITINGN/ASponsored by Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Actively Recruiting
PhaseN/A
SponsorShanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Started2024-05-27
Est. completion2025-04-28
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06461260
Summary
The study utilizes a non-invasive deep brain stimulation (temporal interference, TI) technique primarily targeting the amygdala to preliminarily explore the clinical efficacy and potential mechanisms of MRI-compatible TI technology in regulating the amygdala in depressive disorders, providing a more comprehensive basis for the application of TI technology.
Eligibility
Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria: * Participants must be aged between 18 and 65, with no gender restrictions; * A diagnosis of depression made by the study physician based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); * HAMD-17 score of 17 or higher; * Participants must not have changed their antidepressant medication regimen from 30 days prior to signing the informed consent form through the duration of the experiment; * Eligible individuals or their authorized representatives must demonstrate, as assessed by the study physician, a comprehensive understanding of the study's objectives and procedures, be capable of adhering to the requirements set forth in the study protocol, and provide their signature on the informed consent form. Exclusion Criteria: * Eligible participants must not have a history of psychiatric or neurological disorders, as judged by the investigator, which may impact the evaluation of the study's efficacy; * Participants must not have a history of seizures or prior episodes of epilepsy; * The presence of metallic foreign objects within the cranial structure or metallic cardiac implants; * Participants must not have a diagnosis of organic brain disease, nor a history of significant cranial trauma or neurosurgical intervention; * Participants received electroconvulsive therapy or other physical therapies (such as transcranial magnetic stimulation therapy); * The researcher evaluated the individual's mental state and determined it to present a significant risk of suicidal ideation or behavior; * Pregnant or breastfeeding; * Participants who are concurrently engaged in other clinical interventional trials; * Participants presenting with other circumstances that the investigator deems unsuitable for the intervention being studied
Conditions2
DepressionMajor Depressive Disorder
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorShanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Started2024-05-27
Est. completion2025-04-28
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06461260